ND3 - META-ANALYSIS OF REAL-WORLD ADHERENCE AND PERSISTENCE OF MAINTENANCE ONCE- OR TWICE-DAILY ORAL DISEASE-MODIFYING DRUGS (DIMETHYL FUMARATE, FINGOLIMOD, AND TERIFLUNOMIDE) IN MULTIPLE SCLEROSIS

To conduct meta-analyses of reported rates of once- or twice-daily oral maintenance disease-modifying drugs (DMDs) (ie, dimethyl fumarate, fingolimod, and teriflunomide) adherence and/or persistence across real-world data sources in patients with multiple sclerosis (MS). A systematic literature review of studies published between January 2010-April 2018 evaluating adherence and/or persistence with once- or twice-daily oral DMDs was performed....